ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,721
Diagnostic referrals
1,079
Outstanding pathways
354

Screening pathway

  1. Screening5,721Encounters
  2. Positive finding2,032Documented findings
  3. Referral1,079Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 69.

Participant insight

Expanded synthetic participant 0888 · EXP-0888Synthetic · Site C

Full participant history through 2028-01-06, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-10-21
  4. · Diagnostic referral · EXP-0888-T-R
  5. · Contact attempt · Reached
  6. · Barrier documented · Transport difficulty
  7. · Barrier documented · Appointment coordination
  8. · Diagnostic booking · Initial booking
  9. · Navigation intervention · Coordination support
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · High-grade lesion
  13. · Follow-up disposition · Resolved · EXP-0888-T-R
  14. · Treatment · Synthetic precancer treatment
  15. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-08-12
  16. · Screening · HPV DNA · Repeat · Prior VIA positive
  17. · Screening result · HPV DNA · HPV not detected · Adequate
  18. · Surveillance · HPV DNA · Surveillance · After treatment
  19. · Surveillance result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0915 · Expanded synthetic participant 0915Site B — Peri-Urban Access Programme
EXP-0916 · Expanded synthetic participant 0916Site B — Peri-Urban Access Programme
EXP-0917 · Expanded synthetic participant 0917Site D — Community Engagement Programme
EXP-0918 · Expanded synthetic participant 0918Site A — Urban Referral Hub
EXP-0919 · Expanded synthetic participant 0919Site A — Urban Referral Hub
EXP-0920 · Expanded synthetic participant 0920Site C — Rural Outreach Programme
EXP-0921 · Expanded synthetic participant 0921Site A — Urban Referral Hub
EXP-0922 · Expanded synthetic participant 0922Site A — Urban Referral Hub
EXP-0923 · Expanded synthetic participant 0923Site D — Community Engagement Programme
EXP-0924 · Expanded synthetic participant 0924Site B — Peri-Urban Access Programme
EXP-0925 · Expanded synthetic participant 0925Site A — Urban Referral Hub
EXP-0926 · Expanded synthetic participant 0926Site A — Urban Referral Hub
EXP-0927 · Expanded synthetic participant 0927Site D — Community Engagement Programme
EXP-0928 · Expanded synthetic participant 0928Site D — Community Engagement Programme
EXP-0929 · Expanded synthetic participant 0929Site E — Resource-Constrained Navigation Programme
EXP-0931 · Expanded synthetic participant 0931Site E — Resource-Constrained Navigation Programme
EXP-0932 · Expanded synthetic participant 0932Site B — Peri-Urban Access Programme
EXP-0933 · Expanded synthetic participant 0933Site D — Community Engagement Programme
EXP-0935 · Expanded synthetic participant 0935Site E — Resource-Constrained Navigation Programme
EXP-0936 · Expanded synthetic participant 0936Site E — Resource-Constrained Navigation Programme
EXP-0937 · Expanded synthetic participant 0937Site E — Resource-Constrained Navigation Programme
EXP-0939 · Expanded synthetic participant 0939Site E — Resource-Constrained Navigation Programme
EXP-0940 · Expanded synthetic participant 0940Site B — Peri-Urban Access Programme
EXP-0942 · Expanded synthetic participant 0942Site C — Rural Outreach Programme
EXP-0943 · Expanded synthetic participant 0943Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1970
HPV DNA
3024
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.